aap Implantate AG (F:AAQ1) — Market Cap & Net Worth
Market Cap & Net Worth: aap Implantate AG (AAQ1)
aap Implantate AG (F:AAQ1) has a market capitalization of $26.84 Million (€22.96 Million) as of September 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #24227 globally and #2092 in its home market, demonstrating a -7.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying aap Implantate AG's stock price €1.56 by its total outstanding shares 14716976 (14.72 Million). Also see aap Implantate AG total assets for a full breakdown of the balance sheet.
aap Implantate AG Market Cap History: 2015 to 2026
aap Implantate AG's market capitalization history from 2015 to 2026. Data shows change from $234.17 Million to $26.84 Million (-20.36% CAGR). Also see aap Implantate AG operating cash flow efficiency for how efficiently the company converts equity into cash flow.
aap Implantate AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how aap Implantate AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check aap Implantate AG (AAQ1) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.73x
aap Implantate AG's market cap is 1.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $210.25 Million | $10.49 Million | $14.63 Million | 20.05x | 14.37x |
| 2017 | $302.99 Million | $10.90 Million | -$9.27 Million | 27.79x | N/A |
| 2018 | $183.24 Million | $10.78 Million | -$7.67 Million | 17.00x | N/A |
| 2019 | $68.48 Million | $11.74 Million | -$19.44 Million | 5.83x | N/A |
| 2020 | $51.19 Million | $9.33 Million | -$8.79 Million | 5.49x | N/A |
| 2021 | $50.24 Million | $12.17 Million | -$2.70 Million | 4.13x | N/A |
| 2022 | $22.71 Million | $11.52 Million | -$2.56 Million | 1.97x | N/A |
| 2023 | $12.65 Million | $11.48 Million | -$7.96 Million | 1.10x | N/A |
| 2024 | $21.16 Million | $12.20 Million | -$3.63 Million | 1.73x | N/A |
Competitor Companies of AAQ1 by Market Capitalization
Companies near aap Implantate AG in the global market cap rankings as of September 19, 2026. Review AAQ1 intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to aap Implantate AG by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
aap Implantate AG Historical Marketcap From 2015 to 2026
Between 2015 and today, aap Implantate AG's market cap moved from $234.17 Million to $ 26.84 Million, with a yearly change of -20.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €26.84 Million | +20.93% |
| 2025 | €22.20 Million | +4.88% |
| 2024 | €21.16 Million | +67.35% |
| 2023 | €12.65 Million | -44.32% |
| 2022 | €22.71 Million | -54.79% |
| 2021 | €50.24 Million | -1.85% |
| 2020 | €51.19 Million | -25.25% |
| 2019 | €68.48 Million | -62.63% |
| 2018 | €183.24 Million | -39.52% |
| 2017 | €302.99 Million | +44.11% |
| 2016 | €210.25 Million | -10.21% |
| 2015 | €234.17 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of aap Implantate AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $26.84 Million USD |
| MoneyControl | $26.84 Million USD |
| MarketWatch | $26.84 Million USD |
| marketcap.company | $26.84 Million USD |
| Reuters | $26.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About aap Implantate AG
aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides hole screws and Repro Bone materials. The company sells its products directly to hospitals, purchasing groups, and hospital… Read more